Showing results (1711-1720 of 1,860) with videos related to

Sort By:
Pageof 186
Respiratory Care|January 17, 2013
Absence of airway secretion accumulation predicts tolerance of noninvasive ventilation in subjects with amyotrophic lateral sclerosisNadia Vandenberghe, Anne-Evelyne Vallet, Thierry Petitjean, et al.
Cell Reports|December 29, 2021
Spatiotemporal localization of proteins in mycobacteriaJunhao Zhu, Ian D Wolf, Charles L Dulberger, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 15, 2024
Nonalcohol-related Cirrhosis Leads to Higher 6-week Mortality After Acute Variceal Bleeding Than Alcohol-related CirrhosisYu Jun Wong, Adam Buckholz, Alyssa Sim, et al.
Journal of Glaucoma|July 14, 2018
A Common Glaucoma-risk Variant of SIX6 Alters Retinal Nerve Fiber Layer and Optic Disc Measures in a European Population: The EPIC-Norfolk Eye StudyAnthony P Khawaja, Michelle P Y Chan, Jennifer L Y Yip, et al.
BMC Pediatrics|February 9, 2010
Control of hyperglycaemia in paediatric intensive care (CHiP): study protocolDuncan Macrae, John Pappachan, Richard Grieve, et al.
Science Advances|June 12, 2020
Mycobacterium tuberculosis clinical isolates carry mutational signatures of host immune environmentsQingyun Liu, Jianhao Wei, Yawei Li, et al.
Mucosal Immunology|November 4, 2025
Protection against reinfection with Mycobacterium tuberculosis extends across heterologous Mtb lineagesAndrew W Simonson, Michael C Chao, Luke E Hood, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Distinct antibody-based signatures and functionality distinguish latent and active pediatric tuberculosisNadege Nziza, Wonyeong Jung, Tina Chen, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Protection against reinfection with Mycobacterium tuberculosis extends across heterologous Mtb lineagesAndrew W Simonson, Michael C Chao, Luke E Hood, et al.
Annals of Hepatology|March 13, 2026
Awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among primary care providers in the four most populous U.S. citiesJeffrey V Lazarus, Trenton M White, Melina Manolas, et al.
Pageof 186